日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention

开发阿片类药物疫苗作为治疗阿片类药物使用障碍和预防过量用药的新策略

Tuncturk, Mustafa; Kushwaha, Shikha; Heider, Robin M BS; Oesterle, Tyler; Weinshilboum, Richard; Ho, Ming-Fen

Buprenorphine's Effect on the Human Immune System and Inflammation

丁丙诺啡对人体免疫系统和炎症的影响

Shin, Samuel D; Branning, Rachel; McGinnis, Michele; Shin, Alexandra; Ho, Ming-Fen; Karpyak, Victor M; Oesterle, Tyler

Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder

胰高血糖素样肽-1受体激动剂:治疗酒精使用障碍的新前沿

Oesterle, Tyler S; Ho, Ming-Fen

The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews

迷幻剂在物质使用障碍治疗中的作用:系统评价概述

Correa da Costa, Sabrina; Bormann, Nicholas L; Oesterle, Tyler; McGinnis, Michele T; Ho, Ming-Fen; Vettleson-Trutza, Sara A; Rummans, Teresa; Gold, Mark S

Plasma TREM2 levels, alcohol consumption, and liver enzymes in patients with alcohol use disorder: a sex-dependent relationship involving MS4A6A genetic polymorphism

酒精使用障碍患者的血浆TREM2水平、酒精摄入量和肝酶:与MS4A6A基因多态性相关的性别依赖性关系

Ho, Ming-Fen; Zhang, Cheng; Coombes, Brandon; Biernacka, Joanna; Skime, Michelle; Croarkin, Paul E; Oesterle, Tyler; Karpyak, Victor M; Li, Hu; Weinshilboum, Richard

IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study

IL17RB基因变异与酒精使用障碍患者阿坎酸治疗反应相关:一项基于蛋白质组学的基因组学研究

Ho, Ming-Fen; Zhang, Cheng; Cohan, James S; Tuncturk, Mustafa; Heider, Robin M; Coombes, Brandon J; Biernacka, Joanna; Moon, Irene; Skime, Michelle; Ho, Ada M; Ngo, Quyen; Skillon, Cedric; Croarkin, Paul E; Oesterle, Tyler S; Karpyak, Victor M; Li, Hu; Weinshilboum, Richard M

Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy

雄激素受体介导的药物基因组学表达数量性状位点:对乳腺癌对雄激素受体靶向治疗反应的意义

Gao, Huanyao; Wei, Lixuan; Indulkar, Shreya; Nguyen, Thanh Thanh L; Liu, Duan; Ho, Ming-Fen; Zhang, Cheng; Li, Hu; Weinshilboum, Richard M; Ingle, James N; Wang, Liewei

Corrigendum to "Genetic predisposition to major depressive disorder differentially impacts alcohol consumption and high-risk drinking situations in men and women with alcohol use disorder" [Drug Alcohol Depend. 243 (2023) 109753]

对“重度抑郁症的遗传倾向对患有酒精使用障碍的男性和女性的饮酒量和高风险饮酒情况产生不同的影响”的更正[Drug Alcohol Depend. 243 (2023) 109753]

Karpyak, Victor M; Coombes, Brandon J; Geske, Jennifer R; Pazdernik, Vanessa M; Schneekloth, Terry; Kolla, Bhanu Prakash; Oesterle, Tyler; Loukianova, Larissa L; Skime, Michelle K; Ho, Ada Man-Choi; Ngo, Quyen; Skillon, Cedric; Ho, Ming-Fen; Weinshilboum, Richard; Biernacka, Joanna M

Genetic predisposition to major depressive disorder differentially impacts alcohol consumption and high-risk drinking situations in men and women with alcohol use disorder

遗传易感性导致重度抑郁症对患有酒精使用障碍的男性和女性的饮酒量和高风险饮酒情境的影响不同。

Karpyak, Victor M; Coombes, Brandon J; Geske, Jennifer R; Pazdernik, Vanessa M; Schneekloth, Terry; Kolla, Bhanu Prakash; Oesterle, Tyler; Loukianova, Larissa L; Skime, Michelle K; Ho, Ada Man-Choi; Ngo, Quyen; Skillon, Cedric; Ho, Ming-Fen; Weinshilboum, Richard; Biernacka, Joanna M

Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder.

血浆TNFSF10水平与酒精使用障碍患者的阿坎酸治疗反应相关

Ho Ming-Fen, Zhang Cheng, Moon Irene, Coombes Brandon J, Biernacka Joanna, Skime Michelle, Choi Doo-Sup, Croarkin Paul E, Frye Mark A, Ngo Quyen, Skillon Cedric, Oesterle Tyler S, Karpyak Victor M, Li Hu, Weinshilboum Richard M